A new sensitiser (4) for use in photodynamic therapy (PDT) has been developed to enable control of ROS production as a function of pH. This pH dependent PDT behaviour was tested in HeLa cells and in SCID mice bearing human xenograft pancreatic cancer (BxPC-3) tumours.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c5cc07022h | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!